AlzChem Group Past Earnings Performance
Past criteria checks 6/6
AlzChem Group has been growing earnings at an average annual rate of 12.6%, while the Chemicals industry saw earnings growing at 11.8% annually. Revenues have been growing at an average rate of 9.5% per year. AlzChem Group's return on equity is 21.3%, and it has net margins of 6.3%.
Key information
12.6%
Earnings growth rate
12.7%
EPS growth rate
| Chemicals Industry Growth | 12.4% |
| Revenue growth rate | 9.5% |
| Return on equity | 21.3% |
| Net Margin | 6.3% |
| Next Earnings Update | 30 Apr 2024 |
Recent past performance updates
Recent updates
Revenue & Expenses BreakdownBeta
How AlzChem Group makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 31 Dec 23 | 546 | 35 | 149 | 0 |
| 30 Sep 23 | 533 | 30 | 143 | 0 |
| 30 Jun 23 | 554 | 28 | 140 | 0 |
| 31 Mar 23 | 570 | 30 | 140 | 0 |
| 31 Dec 22 | 550 | 30 | 139 | 0 |
| 30 Sep 22 | 534 | 29 | 136 | 0 |
| 30 Jun 22 | 487 | 28 | 135 | 0 |
| 31 Mar 22 | 454 | 27 | 134 | 0 |
| 31 Dec 21 | 429 | 28 | 133 | 0 |
| 30 Sep 21 | 420 | 27 | 135 | 0 |
| 30 Jun 21 | 406 | 26 | 133 | 0 |
| 31 Mar 21 | 397 | 23 | 129 | 0 |
| 31 Dec 20 | 386 | 20 | 129 | 0 |
| 30 Sep 20 | 370 | 16 | 127 | 0 |
| 30 Jun 20 | 389 | 17 | 127 | 0 |
| 31 Mar 20 | 387 | 17 | 127 | 0 |
| 31 Dec 19 | 385 | 18 | 125 | 0 |
| 30 Sep 19 | 389 | 19 | 124 | 0 |
| 30 Jun 19 | 380 | 18 | 122 | 0 |
| 31 Mar 19 | 380 | 20 | 120 | 0 |
| 31 Dec 18 | 383 | 23 | 118 | 0 |
| 30 Sep 18 | 380 | 22 | 114 | 0 |
| 30 Jun 18 | 398 | 32 | 123 | 0 |
| 31 Mar 18 | 364 | 21 | 115 | 0 |
| 31 Dec 17 | 361 | 20 | 114 | 0 |
| 30 Sep 17 | 356 | 22 | 115 | 0 |
| 31 Dec 16 | 333 | 15 | 111 | 0 |
| 30 Sep 16 | 331 | 12 | 108 | 0 |
| 31 Dec 15 | 329 | 15 | 106 | 0 |
| 31 Dec 14 | 298 | 14 | 98 | 0 |
| 31 Dec 13 | 302 | 17 | 93 | 0 |
Quality Earnings: ACT has high quality earnings.
Growing Profit Margin: ACT's current net profit margins (6.3%) are higher than last year (5.5%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: ACT's earnings have grown by 12.6% per year over the past 5 years.
Accelerating Growth: ACT's earnings growth over the past year (15.2%) exceeds its 5-year average (12.6% per year).
Earnings vs Industry: ACT earnings growth over the past year (15.2%) exceeded the Chemicals industry -19.4%.
Return on Equity
High ROE: ACT's Return on Equity (21.3%) is considered high.